Hospital Clínico San Carlos de Madrid -ko ikertzaileekin lankidetzan egindako argitalpenak (25)

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Real-life data of immune recovery using bictegravir/emtricitabine/ tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 3, pp. 595-607

  3. Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain

    HIV Medicine

  4. Subclinical atherosclerosis burden in carotid and femoral territories in HIV subjects: relationships with HIV and non-HIV related factors

    BMC Infectious Diseases, Vol. 24, Núm. 1

2023

  1. Differences in the inflammatory response among hospitalized patients with distinct variants of SARS-CoV-2

    Frontiers in Immunology, Vol. 14

  2. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

    EBioMedicine, Vol. 95, pp. 104773

  3. Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study

    The Lancet Microbe, Vol. 4, Núm. 1, pp. e21-e28

  4. Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors

    Biomedicines, Vol. 11, Núm. 4

2022

  1. Effect of EARLY administration of DEXamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome (EARLY-DEX COVID-19): study protocol for a randomized controlled trial

    Trials, Vol. 23, Núm. 1

  2. Eosinophilic myocarditis due to Toxocara infection

    Hellenic Journal of Cardiology, Vol. 68, pp. 74-75

  3. Low-dose Radiation Therapy in the Management of COVID-19 Pneumonia (LOWRAD-Cov19). Final results of a prospective phase I–II trial: LOWRAD-Cov19. Final report

    Radiotherapy and Oncology, Vol. 171, pp. 25-29

  4. Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19

    Life science alliance, Vol. 5, Núm. 4

2021

  1. Low-Dose Radiation Therapy in the Management of Coronavirus Disease 2019 (COVID-19) Pneumonia (LOWRAD-Cov19): Preliminary Report

    International Journal of Radiation Oncology Biology Physics, Vol. 109, Núm. 4, pp. 880-885

  2. Serological tests in the detection of SARS-CoV-2 antibodies

    Diagnostics, Vol. 11, Núm. 4

2019

  1. Atypical renal failure

    Revista Clinica Espanola, Vol. 219, Núm. 5, pp. 279

2016

  1. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)

    European Journal of Internal Medicine, Vol. 29, pp. 59-64

  2. Tuberculosis and immigration in an area of southwest Madrid

    International Journal of Tuberculosis and Lung Disease, Vol. 20, Núm. 4, pp. 530-535

2015

  1. Cystatin C as an early marker of acute kidney injury in septic shock

    Revista Clinica Espanola, Vol. 215, Núm. 2, pp. 83-90

2002

  1. Disabling lumbar pain in a 53-year old woman

    Revista Clinica Espanola, Vol. 202, Núm. 5, pp. 291-292

  2. Hypokalemia-induced paraplegia secondary to acute diarrhea

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 19, Núm. 2, pp. 76-78